With the winter flu season, the outpatient prescription drug market is shrinking. In January and February of this year, the prescription size decreased by 6% from last year. The outpatient prescription drug market has been sluggish since the end of last year. It is analyzed that the prescription drug market has also been affected by a sharp decline due to the prolonged COVID-19.

According to the drug research institute UBIST on the 17th, the cumulative outpatient prescription amount in January and February was ₩2,315 billion, a 6.3% decrease from the same period last year. The prescription amount in January was down 7.0% from the previous year, followed by a 5.6% decline in February.